Maarten Jacobus Postma (M J Postma, Maarten Postma, Maarten J Postma)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 59

Top Topics

Atrial Fibrillation

Systematic Review

Metastatic Breast Cancer

Top Venues

Infectious diseases and therapy

PharmacoEconomics - open

Expert review of vaccines

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Clazinus Veijer, Marinus H van Hulst, Benjamin Friedrichson, Maarten Jacobus Postma, Antoinette D I van Asselt
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review. PharmacoEconomics 42 (6) (2024)
Leslie R Zwerwer, Jan Andreas Kloka, Simon van der Pol, Maarten Jacobus Postma, Kai Zacharowski, Antoinette D I van Asselt, Benjamin Friedrichson
Mechanical ventilation as a major driver of COVID-19 hospitalization costs: a costing study in a German setting. Health economics review 14 (1) (2024)
David J Nijssen, Kiedo Wienholts, Maarten Jacobus Postma, Jurriaan B Tuynman, Wilhelmus Adrianus Bemelman, Wytze Laméris, Roel Hompes
The economic impact of anastomotic leakage after colorectal surgery: a systematic review. Techniques in coloproctology 28 (1) (2024)
Florian Zeevat, Joost J M Simons, Tjalke A Westra, Jan C Wilschut, Nina M van Sorge, Cornelis Boersma, Maarten Jacobus Postma
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach. Infectious diseases and therapy 13 (3) (2024)
Olga Pitsillidou, Panagiotis Petrou, Maarten Jacobus Postma
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus. PharmacoEconomics - open 8 (3) (2024)
Florian Zeevat, Joost J M Simons, Tjalke A Westra, Jan C Wilschut, Nina M van Sorge, Cornelis Boersma, Maarten Jacobus Postma
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach. Infectious diseases and therapy 13 (3) (2024)
Clazinus Veijer, Marinus H van Hulst, Benjamin Friedrichson, Maarten Jacobus Postma, Antoinette D I van Asselt
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review. PharmacoEconomics (2024)
Clazinus Veijer, Marinus H van Hulst, Benjamin Friedrichson, Maarten Jacobus Postma, Antoinette D I van Asselt
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review. PharmacoEconomics 42 (6) (2024)
Florian Zeevat, Joost J M Simons, Tjalke A Westra, Jan C Wilschut, Nina M van Sorge, Cornelis Boersma, Maarten Jacobus Postma
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach. Infectious diseases and therapy 13 (3) (2024)
Lotte Westerink, Sharon Wolters, Guiling Zhou, Arjan Postma, Cornelis Boersma, Job Frank Martien van Boven, Maarten Jacobus Postma
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade. The European journal of health economics : HEPAC : health economics in prevention and care (2024)
Olga Pitsillidou, Panagiotis Petrou, Maarten Jacobus Postma
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus. PharmacoEconomics - open (2024)
Florian Zeevat, Joost J M Simons, Tjalke A Westra, Jan C Wilschut, Nina M van Sorge, Cornelis Boersma, Maarten Jacobus Postma
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach. Infectious diseases and therapy 13 (3) (2024)
Clazinus Veijer, Marinus H van Hulst, Benjamin Friedrichson, Maarten Jacobus Postma, Antoinette D I van Asselt
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review. PharmacoEconomics 42 (6) (2024)
Florian Zeevat, Joost J M Simons, Tjalke A Westra, Jan C Wilschut, Nina M van Sorge, Cornelis Boersma, Maarten Jacobus Postma
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach. Infectious diseases and therapy (2024)
Olga Pitsillidou, Panagiotis Petrou, Maarten Jacobus Postma
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus. PharmacoEconomics - open 8 (3) (2024)
David J Nijssen, Kiedo Wienholts, Maarten Jacobus Postma, Jurriaan B Tuynman, Wilhelmus Adrianus Bemelman, Wytze Laméris, Roel Hompes
The economic impact of anastomotic leakage after colorectal surgery: a systematic review. Techniques in coloproctology 28 (1) (2024)
Olga Pitsillidou, Panagiotis Petrou, Maarten Jacobus Postma
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus. PharmacoEconomics - open 8 (3) (2024)
Simon van der Pol, Maarten Jacobus Postma, Cornelis Boersma
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands. The European journal of health economics : HEPAC : health economics in prevention and care (2024)
Leslie R Zwerwer, Jan Andreas Kloka, Simon van der Pol, Maarten Jacobus Postma, Kai Zacharowski, Antoinette D I van Asselt, Benjamin Friedrichson
Mechanical ventilation as a major driver of COVID-19 hospitalization costs: a costing study in a German setting. Health economics review 14 (1) (2024)
Olga Pitsillidou, Panagiotis Petrou, Maarten Jacobus Postma
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus. PharmacoEconomics - open 8 (3) (2024)
Olga Pitsillidou, Panagiotis Petrou, Maarten Jacobus Postma
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus. PharmacoEconomics - open 8 (3) (2024)
Florian Zeevat, Joost J M Simons, Tjalke A Westra, Jan C Wilschut, Nina M van Sorge, Cornelis Boersma, Maarten Jacobus Postma
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach. Infectious diseases and therapy (2024)
David J Nijssen, Kiedo Wienholts, Maarten Jacobus Postma, Jurriaan B Tuynman, Wilhelmus Adrianus Bemelman, Wytze Laméris, Roel Hompes
The economic impact of anastomotic leakage after colorectal surgery: a systematic review. Techniques in coloproctology 28 (1) (2024)
Florian Zeevat, Joost J M Simons, Tjalke A Westra, Jan C Wilschut, Nina M van Sorge, Cornelis Boersma, Maarten Jacobus Postma
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach. Infectious diseases and therapy 13 (3) (2024)
David J Nijssen, Kiedo Wienholts, Maarten Jacobus Postma, Jurriaan B Tuynman, Wilhelmus Adrianus Bemelman, Wytze Laméris, Roel Hompes
The economic impact of anastomotic leakage after colorectal surgery: a systematic review. Techniques in coloproctology 28 (1) (2024)
Clazinus Veijer, Marinus H van Hulst, Benjamin Friedrichson, Maarten Jacobus Postma, Antoinette D I van Asselt
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review. PharmacoEconomics 42 (6) (2024)
Tanja Fens, Lisa Aniek de Jong, Bregt Kappelhoff, Cornelis Boersma, Maarten Jacobus Postma
Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran. Journal of market access & health policy 11 (1) (2023)
Robbert Bakema, Daria Smirnova, Despina Biri, Janwillem W H Kocks, Maarten Jacobus Postma, Lisa Aniek de Jong
The Use of eHealth for Pharmacotherapy Management With Patients With Respiratory Disease, Cardiovascular Disease, or Diabetes: Scoping Review. Journal of medical Internet research 25 (2023)
Olga Pitsillidou, Panagiotis Petrou, Maarten Jacobus Postma
Implementing a Managed Entry Agreement Framework in Cyprus. Expert review of pharmacoeconomics & outcomes research (2023)
Jos Luttjeboer, Joost J M Simons, Tjalke A Westra, Jan C Wilschut, Cornelis Boersma, Maarten Jacobus Postma, Jurjen van der Schans
An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands. Infectious diseases and therapy (2023)
Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten Jacobus Postma, Roel D Freriks
Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses. Expert review of vaccines (2023)
Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten Jacobus Postma, Roel D Freriks
Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses. Expert review of vaccines 22 (1) (2023)
Jeroen H J Paulissen, Ahmed H Seddik, Kyle J Dunton, Christopher J Livings, Marinus H van Hulst, Maarten Jacobus Postma, Lisa Aniek de Jong, Roel D Freriks
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland. The European journal of health economics : HEPAC : health economics in prevention and care (2023)
Alexander V van Schoonhoven, Marcel H Schöttler, Erik H Serné, Patrick P G Schrömbges, Maarten Jacobus Postma, Cornelis Boersma
The health and budget impact of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in the Netherlands. Journal of medical economics (2023)
Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten Jacobus Postma, Roel D Freriks
Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses. Expert review of vaccines 22 (1) (2023)
Adila T Syamlan, Sovia Salamah, Firas Farisi Alkaff, Yogi E Prayudi, Muhammad Kamil, Abyan Irzaldy, Azimatul Karimah, Maarten Jacobus Postma, Fredrick Dermawan Purba, Bustanul Arifin
Mental health and health-related quality of life among healthcare workers in Indonesia during the COVID-19 pandemic: a cross-sectional study. BMJ open 12 (4) (2022)
Edith M Heintjes, Anastassia Anastassopoulou, Josephina G Kuiper, Aikaterini Bilitou, Fernie J A Penning-van Beest, Ron M C Herings, Maarten Jacobus Postma, Johan Wouter Jukema
Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands. Current medical research and opinion (2022)
Bart Heeg, Andrea Garcia, Sophie van Beekhuizen, Andre Verhoek, Ilse van Oostrum, Satrajit Roychoudhury, Joseph Christopher Cappelleri, Maarten Jacobus Postma, Mario Johannes Nicolaas Martinus Ouwens
Novel and existing flexible survival methods for network meta-analyses. Journal of comparative effectiveness research (2022)
Panagiotis Petrou, Olga Pitsillidou, Maarten Jacobus Postma
The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and France. Journal of medical economics 25 (1) (2022)
Lotte Westerink, Jelmer Lennart Jens Nicolai, Maarten Jacobus Postma, Job Frank Martien van Boven, Cornelis Boersma
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD). PharmacoEconomics - open 6 (5) (2022)
Simon van der Pol, Paula Rojas Garcia, Maarten Jacobus Postma, Fernando Antoñanzas Villar, Antoinette D I van Asselt
Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review. PharmacoEconomics 39 (12) (2021)
Auliya Abdurrohim Suwantika, Febby V Purwadi, Neily Zakiyah, Irma Melyani Puspitasari, Rizky Abdulah, Ajeng Diantini, Cornelis Boersma, Maarten Jacobus Postma
Multi-criteria decision analysis to prioritize the introduction of new vaccines in Indonesia by using the framework of the strategic multi-attribute ranking tool for vaccines (SMART vaccines). Expert review of vaccines 20 (1) (2021)
Christophe Sauboin, Jovan Mihajlović, Maarten Jacobus Postma, Regine Geets, Djurdja Antic, Baudouin Standaert
Informing decision makers seeking to improve vaccination programs: case-study Serbia. Journal of market access & health policy 9 (1) (2021)
Onwipa Rochanathimoke, Arthorn Riewpaiboon, Naiyana Praditsitthikorn, Piyanit Tharmaphornpilas, Suchada Jiamsiri, Montarat Thavorncharoensap, Maarten Jacobus Postma
Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand. Expert review of pharmacoeconomics & outcomes research 21 (4) (2021)
Tanja Fens, Guiling Zhou, Maarten Jacobus Postma, Eugene P van Puijenbroek, Job Frank Martien van Boven
Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed? Expert opinion on pharmacotherapy 22 (7) (2021)
Lisa Aniek de Jong, Alexander Victor van Schoonhoven, Hinko Stephan Hofstra, Maarten Jacobus Postma, Bart van Hoek
Budget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The Netherlands. Journal of medical economics 24 (1) (2021)
Auliya Abdurrohim Suwantika, Cornelis Boersma, Maarten Jacobus Postma
The potential impact of COVID-19 pandemic on the immunization performance in Indonesia. Expert review of vaccines 19 (8) (2020)
Simon van der Schans, Gert T Vondeling, Qi Cao, Simon van der Pol, Sipke Visser, Maarten Jacobus Postma, Mark H Rozenbaum
The impact of patent expiry on drug prices: insights from the Dutch market. Journal of market access & health policy 9 (1) (2020)
Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Jacobus Postma, Mondher Toumi
Health economic evaluation of gene replacement therapies: methodological issues and recommendations. Journal of market access & health policy 8 (1) (2020)
Boudewijn J H Dierick, Thys van der Molen, Bertine M J Flokstra-de Blok, Antonella Muraro, Maarten Jacobus Postma, Janwillem W H Kocks, Job F M van Boven
Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert review of pharmacoeconomics & outcomes research 20 (5) (2020)
Lisa Aniek de Jong, Judith J Gout-Zwart, Marina van den Bosch, Mike Koops, Maarten Jacobus Postma
Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis. Journal of medical economics 22 (4) (2019)
Afifah Machlaurin, Simon van der Pol, Didik Setiawan, Tjip S van der Werf, Maarten Jacobus Postma
Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review. Expert review of vaccines 18 (9) (2019)
Maartje S Jacobs, Jeroen F Schouten, Pieter T de Boer, Mikael Hoffmann, Lars-Åke Levin, Maarten Jacobus Postma
Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands. Current medical research and opinion 34 (10) (2018)
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham, Lars-Ake Levin, Maarten Jacobus Postma, Nicolas Touchot
Approaches to manage 'affordability' of high budget impact medicines in key EU countries. Journal of market access & health policy 6 (1) (2018)
Gertruud Haitsma, Himanshu Patel, Parthasarathi Gurumurthy, Maarten Jacobus Postma
Access to anti-cancer drugs in India: is there a need to revise reimbursement policies? Expert review of pharmacoeconomics & outcomes research 18 (3) (2018)
Didik Setiawan, Monika Puri Oktora, Raymond Hutubessy, Arthorn Riewpaiboon, Maarten Jacobus Postma
The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review. Expert review of vaccines 16 (9) (2017)
Maartje S Jacobs, M W J van Leent, R G Tieleman, F G A Jansman, Q Cao, Maarten Jacobus Postma, M van Hulst
Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands. Journal of medical economics 20 (12) (2017)
Pieter T de Boer, Britt M van Maanen, Oliver Damm, Bernhard Ultsch, Franklin C K Dolk, Pascal Crépey, Richard Pitman, Jan C Wilschut, Maarten Jacobus Postma
A systematic review of the health economic consequences of quadrivalent influenza vaccination. Expert review of pharmacoeconomics & outcomes research 17 (3) (2017)
Onwipa Rochanathimoke, Arthorn Riewpaiboon, Maarten Jacobus Postma, Wirawan Thinyounyong, Montarat Thavorncharoensap
Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand. Expert review of pharmacoeconomics & outcomes research 18 (2) (2017)